insights_auto
Why is ORX down 16,73%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
0,87 SEK
arrow_downward
-16,73%(-0,17) 1D
12 қар., 17:29:50 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
1,04 SEK
High
1,05 SEK
Low
0,80 SEK
Mkt. cap
304,20 млн
Avg. vol.
613,79 м.
Volume
3,83 млн
P/E ratio
0,04
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
1,04 SEK
High
1,05 SEK
Low
0,80 SEK
Mkt. cap
304,20 млн
Avg. vol.
613,79 м.
Volume
3,83 млн
P/E ratio
0,04
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
Startup Fortune
·
57 минут бұрын
Nscale updates its NYSE IPO filing as losses widen and the $35bn target wobbles
Yahoo Finance
·
36 минут бұрын
Stock Market: Will S&P 500 Open Up or Down Today?
Benzinga
·
26 минут бұрын
Nasdaq Down 100 Points As Nvidia Shares Fall: Investor Sentiment Improves, But Greed Index Remains In ‘Fear’ Zone
Bloomberg.com
·
2 сағат бұрын
Asian Stocks Set for Cautious Open on Nvidia, Oil: Markets Wrap
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com